Top

Published in:

01-06-2017

Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ

Authors: Christopher Thomas Veal, Vicki Hart, Susan G. Lakoski, John M. Hampton, Ronald E. Gangnon, Polly A. Newcomb, Stephen T. Higgins, Amy Trentham-Dietz, Brian L. Sprague

Published in: Journal of Cancer Survivorship | Issue 3/2017

Abstract

Purpose

Women diagnosed with ductal carcinoma in situ (DCIS) of the breast are at greater risk of dying from cardiovascular disease and other causes than from breast cancer, yet associations between health-related behaviors and mortality outcomes after DCIS have not been well studied.

Methods

We examined the association of body mass index, physical activity, alcohol consumption, and smoking with mortality among 1925 women with DCIS in the Wisconsin In Situ Cohort study. Behaviors were self-reported through baseline interviews and up to three follow-up questionnaires. Cox proportional hazards regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for mortality after DCIS, with adjustment for patient sociodemographic, comorbidity, and treatment factors.

Results

Over a mean of 6.7 years of follow-up, 196 deaths occurred. All-cause mortality was elevated among women who were current smokers 1 year prior to diagnosis (HR = 2.17 [95% CI 1.48, 3.18] vs. never smokers) and reduced among women with greater physical activity levels prior to diagnosis (HR = 0.55 [95% CI: 0.35, 0.87] for ≥5 h per week vs. no activity). Moderate levels of post-diagnosis physical activity were associated with reduced all-cause mortality (HR = 0.31 [95% CI 0.14, 0.68] for 2–5 h per week vs. no activity). Cancer-specific mortality was elevated among smokers and cardiovascular disease mortality decreased with increasing physical activity levels.

Conclusions

There are numerous associations between health-related behaviors and mortality outcomes after a DCIS diagnosis.

Implications for cancer survivors

Women diagnosed with DCIS should be aware that their health-related behaviors are associated with mortality outcomes.

Lee RJ, Vallow LA, McLaughlin SA, Tzou KS, Hines SL, Perterson JL. Ductal carcinoma in situ of the breast. International Journal of Surgical Oncology. 2012. doi:10.1155/2012/123549

Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160(7):953–8. doi:10.1001/archinte.160.7.953.CrossRefPubMed

Society AC. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.

Sprague BL, Trentham-Dietz A. Prevalence of breast carcinoma in situ in the United States. J Am Med Assoc. 2009;302(8):846–8. doi:10.1001/jama.2009.1211.CrossRef

SEER Cancer Statistics Review, 1975-2012 (2015) National Cancer Institute. http://seer.cancer.gov/csr/1975_2012/. Accessed 2015 Jul 2

Berkman A, Cole FB, Ades P, Dickey S, Higgins S, Trentham-Dietz A, et al. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014;148(2):407–13. doi:10.1007/s10549-014-3168-3.CrossRefPubMedPubMedCentral

Sprague BL, Trentham-Dietz A, Nichols HB, Hampton JM, Newcomb PA. Change in lifesytle behaviors and medication use after a diagnosis of ductal carcinoma in situ. Breast Cancer Res Treat. 2010;124(2):487–95. doi:10.1007/s10549-010-0869-0.CrossRefPubMedPubMedCentral

Khadanga S, Hart V, Ba Y, Higgins ST, Ades PA, Trentham-Dietz A, et al. Living situation and socioeconomic factors are associated with change in health behavior after a diagnosis of ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2015;25(1):1–7. doi:10.1158/1055-9965.EPI-15-0726.

Ligibel J, Partridge A, Giobbie-Hurder A, Golshan M, Emmons K, Winer E. Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ. Ann Surg Oncol. 2009;16(1):106–12. doi:10.1245/s10434-008-0174-x.CrossRefPubMed

10.

McLaughlin VH, Trentham-Dietz A, Hampton JM, Newcomb PA, Sprague BL. Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ. Cancer Epidemiol Biomark Prev. 2014;23(3):450–60. doi:10.1158/1055-9965.EPI-13-0899.CrossRef

11.

Berkman A, Trentham-Dietz A, Dittus K, Hart V, Vatovec C, King J, James T, Lakoski S, Sprague B. Health behavior change following a diagnosis of ductal carcinoma in situ: an opportunity to improve health outcomes. Preventive Medicine. 2015. doi:10.1016/j.ypmed.2015.03.020

12.

Borch KB, Braaten T, Lund E, Weiderpass E. Physical activity and mortality among Norwegian women—the Norwegian Women and Cancer Study. Clin Epidemiol. 2011;3:229–35. doi:10.2147/CLEP.S22681.CrossRefPubMedPubMedCentral

13.

Gellert C, Schöttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012;172(11):837–44. doi:10.1001/archinternmed.2012.1397.CrossRefPubMed

14.

Shaw BA, Agahi N. Smoking and physical inactivity patterns during midlife as predictors of all-cause mortality and disability: a 39-year prospective study. Eur J Ageing. 2014;11(3):195–204.CrossRefPubMed

15.

Hamilton MT, Hamilton DG, Zderic TW. Sedentary behavior as a mediator of type 2 diabetes. Med Sport Sci. 2014;60:11–26. doi:10.1159/000357332.CrossRefPubMedPubMedCentral

16.

Kim Y, Wilkens LR, Park SY, Goodman MT, Monroe KR, Kolonel LN. Association between various sedentary behaviours and all-cause, cardiovascular disease and cancer mortality: the Multiethnic Cohort Study. Int J Epidemiol. 2013;42(4):1040–56. doi:10.1093/ije/dyt108.CrossRefPubMedPubMedCentral

17.

Vilablanca AC, McDonald JM, Rutledge JC. Smoking and cardiovascular disease. Clin Chest Med. 2000;21(1):159–72.CrossRef

18.

George S, Irwin M, Smith A, Neuhouser M, Reedy J, McTiernan A, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22(4):589–98. doi:10.1007/s10552-011-9732-9.CrossRefPubMedPubMedCentral

19.

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Jr HCW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105.CrossRefPubMed

20.

Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122(7):481–6.CrossRefPubMed

21.

Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med. 1995;333(11):677–85.CrossRefPubMed

22.

Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78.CrossRefPubMed

23.

Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–72.CrossRefPubMed

24.

Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. J Am Med Assoc. 2007;298(17):2028–37.CrossRef

25.

Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomark Prev. 2009;18(5):1409. doi:10.1158/1055-9965.EPI-08-1094.CrossRef

26.

Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8. doi:10.1200/JCO.2005.01.079.CrossRefPubMed

27.

Kawai M, Tomotaki A, Miyata H, Iwamoto T, Niikura N, Anan K, et al. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry. Cancer Med. 2016. doi:10.1002/cam4.678.

28.

Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, et al. Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. J Clin Oncol. 2016;34(11).

29.

Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, John EM, Giuliano AR, et al. Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer. Ann Epidemiol. 2015;25(11):824–31. doi:10.1016/j.annepidem.2015.08.007.CrossRefPubMedPubMedCentral

30.

Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt R, et al. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Epidemiology. 2012;136(2):521–33. doi:10.1007/s10549-012-2276-1.

31.

Wolf AM, Hunter DJ, Colditz GA, Manson JE, Stampfer MJ, Corsano KA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991–9.CrossRefPubMed

32.

Sprague B, McLaughlin V, Hampton J, Newcomb P, Trentham-Dietz A. Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat. 2013;141(1):145–54. doi:10.1007/s10549-013-2670-3.CrossRefPubMedPubMedCentral

33.

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed

34.

Schafer JL. Analysis of incomplete multivariate data. London: Chapman and Hall; 1997.CrossRef

35.

Holmes MD, Murin S, Chen WY, Kroenke CH, Spiegelman D, Colditz GA. Smoking and survival after breast cancer diagnosis. Int J Cancer. 2007;120(12):2672–7. doi:10.1002/ijc.22575.CrossRefPubMed

36.

Padron-Monedero A, Tannenbaum SL, Koru-Sengul T, Miao F, Hansra D, Lee DJ, et al. Smoking and survival in female breast cancer patients. Breast Cancer Res Treat. 2015;150(2):395–403. doi:10.1007/s10549-015-3317-3.CrossRefPubMed

37.

Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753–65. doi:10.1007/s12032-010-9536-x.CrossRefPubMed

38.

Zhong S, Jiang T, Ma T, Zhang X, Tang J, Chen W, et al. Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies. Eur J Epidemiol. 2014;29(6):391–404. doi:10.1007/s10654-014-9916-1.CrossRefPubMed

39.

Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008;19(10):1319–28. doi:10.1007/s10552-008-9203-0.CrossRefPubMedPubMedCentral

40.

Kwan ML, Chen WY, Kroenke CH, Weltzien E, Beasley JM, Nechuta SJ, et al. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012;132(2):729–39. doi:10.1007/s10549-011-1914-3.CrossRefPubMed

41.

Widschwendter P, Friedl TW, Schwentner L, Degregorio N, Jaeger B, Schramm A, et al. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial. Breast Cancer Res. 2015;17(129):1–11.

42.

Chan DS, Vieria A, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14. doi:10.1093/annonc/mdu042.CrossRefPubMedPubMedCentral

43.

Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298(17):2028–37. doi:10.1001/jama.298.17.2028. [pii]. 298/17/2028.CrossRefPubMed

44.

Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861–7. doi:10.1001/jama.293.15.1861.CrossRefPubMed

45.

Borrell LN, Samuel L. Body mass index categories and mortality risk in US adults: the effect of overweight and obesity on advancing death. Am J Public Health. 2014;104(3):512–9. doi:10.2105/AJPH.2013.301597.CrossRefPubMedPubMedCentral

46.

Ades PA, Savage PD. The obesity paradox: perception vs knowledge. Mayo Clin Proc. 2010;85(2):112–4. doi:10.4065/mcp.2009.0777.CrossRefPubMedPubMedCentral

47.

Flatt SW, Thomson CA, Gold EB, Nartarajan L, Rock CL, Al-Delaimy WK, et al. Low to moderate alcohol intake is not associated with increased mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(3):681–8. doi:10.1158/1055-9965.EPI-09-0927.CrossRefPubMedPubMedCentral

48.

Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, et al. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol. 2013;31(16):1939–46. doi:10.1200/JCO.2012.46.5765.CrossRefPubMedPubMedCentral

Title: Health-related behaviors and mortality outcomes in women diagnosed with ductal carcinoma in situ
Authors: Christopher Thomas Veal
Vicki Hart
Susan G. Lakoski
John M. Hampton
Ronald E. Gangnon
Polly A. Newcomb
Stephen T. Higgins
Amy Trentham-Dietz
Brian L. Sprague
Publication date: 01-06-2017
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 3/2017
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-016-0590-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Implications for cancer survivors

Please log in to get access to this content

Other articles of this Issue 3/2017

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period

Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial

Cervical cancer screening for survivors diagnosed with cancer before age 25

The role of social media use in improving cancer survivors’ emotional well-being: a moderated mediation study

Toward the optimal strategy for sustained weight loss in overweight cancer survivors: a systematic review of the literature

Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer